<ul><li>Eindhoven-based Salvia BioElectronics secures €53M in Series B financing round led by Innovation Industries.</li><li>Funding round includes participation from Invest-NL, EIC Fund, and existing investors like Inkef, Panakès Partners, and more.</li><li>Salvia BioElectronics plans to utilize funds for clinical development of MySalvia Therapy, aiming for FDA approval and regulatory clearances.</li><li>Founded in 2017, Salvia BioElectronics aims to transform migraine treatment through its proprietary neuromodulation technology offering a new hope for chronic migraine sufferers.</li></ul>

Eindhoven’s Salvia BioElectronics raises €53M to advance migraine therapy through neuromodulation tech

Discover more